Literature DB >> 11007352

Chemokines and their receptors in allograft rejection.

W W Hancock1, W Gao, K L Faia, V Csizmadia.   

Abstract

Despite current recognition of over 40 chemokines and more than 18 chemokine receptors, understanding of their role in transplant immunobiology and transplant rejection is extremely limited and fragmentary. Recent literature has demonstrated the presence of chemokines and their receptors in transplants and some studies demonstrate important functional roles.

Mesh：

Substances：

Year:  2000        PMID： 11007352     DOI： 10.1016/s0952-7915(00)00130-8

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  28 in total

1.  Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3.

Authors:  Martin H Oberbarnscheidt; Jeffrey M Walch; Qi Li; Amanda L Williams; John T Walters; Rosemary A Hoffman; Anthony J Demetris; Craig Gerard; Geoffrey Camirand; Fadi G Lakkis
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

2.  Polyomavirus BK Induces Inflammation via Up-regulation of CXCL10 at Translation Levels in Renal Transplant Patients with Nephropathy.

Authors:  Ashraf Kariminik; Shahriar Dabiri; Ramin Yaghobi
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

3.  Transplant rejection and paradigms lost.

Authors:  Terry B Strom
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

4.  Cognate antigen directs CD8+ T cell migration to vascularized transplants.

Authors:  Jeffrey M Walch; Qiang Zeng; Qi Li; Martin H Oberbarnscheidt; Rosemary A Hoffman; Amanda L Williams; David M Rothstein; Warren D Shlomchik; Jiyun V Kim; Geoffrey Camirand; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

5.  Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients.

Authors:  A Hoerning; S Köhler; C Jun; J Lu; J Fu; B Tebbe; S Dolff; T Feldkamp; A Kribben; P F Hoyer; O Witzke
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

Review 6.  NK cells after transplantation: friend or foe.

Authors:  Uzi Hadad; Olivia Martinez; Sheri M Krams
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 7.  Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling.

Authors:  Thangamani Muthukumar; John R Lee; Darshana M Dadhania; Ruchuang Ding; Vijay K Sharma; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplant Rev (Orlando)       Date:  2014-05-27       Impact factor: 3.943

Review 8.  Chemokine receptor antagonists: overcoming developmental hurdles.

Authors:  Richard Horuk
Journal:  Nat Rev Drug Discov       Date:  2008-12-12       Impact factor: 84.694

9.  Identification and validation of biomarkers associated with acute and chronic graft versus host disease.

Authors:  S S Ahmed; X N Wang; J Norden; K Pearce; E El-Gezawy; S Atarod; I Hromadnikova; M Collin; E Holler; A M Dickinson
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

Review 10.  Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.

Authors:  Joshua M Rosenblum; Allan D Kirk
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.